UY31363A1 - Composiciones farmaceuticas que comprenden la combinacion de un agente antiflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas - Google Patents
Composiciones farmaceuticas que comprenden la combinacion de un agente antiflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadasInfo
- Publication number
- UY31363A1 UY31363A1 UY31363A UY31363A UY31363A1 UY 31363 A1 UY31363 A1 UY 31363A1 UY 31363 A UY31363 A UY 31363A UY 31363 A UY31363 A UY 31363A UY 31363 A1 UY31363 A1 UY 31363A1
- Authority
- UY
- Uruguay
- Prior art keywords
- agent
- treatment
- pharmaceutical compositions
- control
- arthritis
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 102000004316 Oxidoreductases Human genes 0.000 title 1
- 108090000854 Oxidoreductases Proteins 0.000 title 1
- 206010003246 arthritis Diseases 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 201000005569 Gout Diseases 0.000 abstract 2
- 206010018634 Gouty Arthritis Diseases 0.000 abstract 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 abstract 1
- 108010093894 Xanthine oxidase Proteins 0.000 abstract 1
- 102100033220 Xanthine oxidase Human genes 0.000 abstract 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 abstract 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 abstract 1
- 229960000590 celecoxib Drugs 0.000 abstract 1
- 229940125532 enzyme inhibitor Drugs 0.000 abstract 1
- 239000002532 enzyme inhibitor Substances 0.000 abstract 1
- 229960001929 meloxicam Drugs 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere a una composicion farmacéutica compuesta por la combinacion sinérgica de un agente antiinflamatorio no esteroideo, conocido como: Meloxicam o Celecoxib, y un agente inhibidor de la enzima xantino oxidasa, conocido como: Alopurinol, además de excipientes farmacéuticamente aceptables, mismos que se encuentran formulados en unidades de dosificacion unicas para ser administradas por vía oral, las cuales están indicadas para el control y tratamiento de la enfermedad gotosa o Gota, artritis gotosa y otras patologías relacionadas. Dichas composiciones farmacéuticas proporcionan un mayor efecto terapéutico y una mayor rapidez de accion farmacologica en menor tiempo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2007011927A MX2007011927A (es) | 2007-09-26 | 2007-09-26 | Composiciones farmaceuticas que comprenden la combinacion de un agente antiinflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31363A1 true UY31363A1 (es) | 2009-03-31 |
Family
ID=40511631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31363A UY31363A1 (es) | 2007-09-26 | 2008-09-25 | Composiciones farmaceuticas que comprenden la combinacion de un agente antiflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2210604A4 (es) |
| AR (1) | AR068560A1 (es) |
| BR (1) | BRPI0817563A2 (es) |
| CL (1) | CL2008002884A1 (es) |
| CO (1) | CO6270220A2 (es) |
| EC (1) | ECSP10010054A (es) |
| MX (1) | MX2007011927A (es) |
| PE (1) | PE20091030A1 (es) |
| UY (1) | UY31363A1 (es) |
| WO (1) | WO2009041798A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2607953A1 (en) | 2005-05-09 | 2006-11-16 | Tap Pharmaceutical Products, Inc. | Methods for treating nephrolithiasis |
| AU2008206231A1 (en) * | 2007-01-19 | 2008-07-24 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents |
| CN103298466B (zh) | 2010-09-10 | 2015-11-25 | 武田制药美国有限公司 | 茶碱和非布索坦的联合治疗方法 |
| CN102973530B (zh) * | 2012-12-14 | 2016-08-03 | 贵州信邦制药股份有限公司 | 一种非布索坦双层肠溶片剂及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008206231A1 (en) * | 2007-01-19 | 2008-07-24 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents |
-
2007
- 2007-09-26 MX MX2007011927A patent/MX2007011927A/es not_active Application Discontinuation
-
2008
- 2008-09-08 EP EP08834122A patent/EP2210604A4/en not_active Withdrawn
- 2008-09-08 WO PCT/MX2008/000123 patent/WO2009041798A1/es not_active Ceased
- 2008-09-08 BR BRPI0817563 patent/BRPI0817563A2/pt not_active Application Discontinuation
- 2008-09-25 UY UY31363A patent/UY31363A1/es not_active Application Discontinuation
- 2008-09-25 AR ARP080104183A patent/AR068560A1/es unknown
- 2008-09-26 CL CL2008002884A patent/CL2008002884A1/es unknown
- 2008-09-26 PE PE2008001680A patent/PE20091030A1/es not_active Application Discontinuation
-
2010
- 2010-03-26 CO CO10036286A patent/CO6270220A2/es not_active Application Discontinuation
- 2010-03-26 EC EC2010010054A patent/ECSP10010054A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2210604A4 (en) | 2010-12-29 |
| PE20091030A1 (es) | 2009-08-06 |
| WO2009041798A8 (es) | 2010-05-14 |
| BRPI0817563A2 (pt) | 2015-03-31 |
| AR068560A1 (es) | 2009-11-18 |
| WO2009041798A1 (es) | 2009-04-02 |
| CO6270220A2 (es) | 2011-04-20 |
| CL2008002884A1 (es) | 2009-03-20 |
| ECSP10010054A (es) | 2010-04-30 |
| EP2210604A1 (en) | 2010-07-28 |
| MX2007011927A (es) | 2009-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020008616A (es) | Rocio de fentanilo sublingual. | |
| UY32989A (es) | Coposiciones terapéuticas concentradas de fosfolípidos | |
| ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
| BRPI1015539A2 (pt) | composições e métodos para tratamento de queimaduras | |
| MA32200B1 (fr) | Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation | |
| UY31322A1 (es) | Amidas heterocíclicas y sus métodos de uso-975 | |
| NZ625592A (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
| AR077284A1 (es) | Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica | |
| PL2244703T3 (pl) | Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii | |
| UY31363A1 (es) | Composiciones farmaceuticas que comprenden la combinacion de un agente antiflamatorio no esteroideo y un agente inhibidor de la xantino oxidasa utiles para el control y tratamiento de la gota, artritis gotosa y enfermedades relacionadas | |
| AR065917A1 (es) | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor | |
| ECSP099734A (es) | Composición farmaceutica que comprende la combinación de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| MX2022005503A (es) | Composiciones farmaceuticas de apixaban de desintegracion oral. | |
| ECSP099649A (es) | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor | |
| ECSP099801A (es) | COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE LA COMBINACIÓN DE UN AGENTE INHIBIDOR DE LA ENZIMA HMG-CoA REDUCTASA Y UN AGENTE INHIBIDOR DE LA ENZIMA LIPASA GASTROINTESTINAL | |
| UY31362A1 (es) | Composiciones farmaceuticas que comprende la combinacion de un agente antiartritico y un agente inhibidor de la interleucina-1, util para el control y tratamiento de la osteoartrosis y enfermedades relacionadas | |
| AR067465A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico | |
| ECSP109996A (es) | Composición farmacéutica que comprende la combinación de un agente antimicrobiano y un agente inhibidor selectivo de la enzima encefalinasa, indicada para el control y tratamiento de la diarrea aguda de origen bacteriano | |
| AR067861A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivamente y un agente benzodiazepinico, indicada para el control y tratamiento de trastornos convulsivos y sindromes epilepticos | |
| AR069538A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias | |
| ECSP10010010A (es) | Composicion farmaceutica que comprende la combinacion de acemetacina, metocarbamol y diacereina, útil en el tratamiento de la artritis reumatoide y enfermedades relacionadas | |
| UY31157A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente inhibidor de la enzima hmg-coa reductasa y un agente inhibidor de la enzima lipasa gastrontestinal | |
| AR067466A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antidepresivo y un agente ansiolitico para el control de trastornos depresivos | |
| UY31095A1 (es) | Composicion farmacéutica que comprende la combinacion de un agente anticonvulsivo y un agente antiviral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20171117 |